Any feedback?
Literature summary extracted from
- Change in blood kinin and plasma porcine pancreatic kallikrein concentrations after oral administration of kallikrein formulation in dog (2011), Biol. Pharm. Bull., 34, 1518-1521.
Application
| EC Number | Application | Comment | Organism |
|---|---|---|---|
| 3.4.21.34 | medicine | porcine pancreatic kallikrein is absorbed after oral administration and to exert its pharmacological action via kinins produced by kininogen degradation in dogs | Sus scrofa |
Organism
| EC Number | Organism | UniProt | Comment | Textmining |
|---|---|---|---|---|
| 3.4.21.34 | Sus scrofa | - |
- |
- |
Source Tissue
| EC Number | Source Tissue | Comment | Organism | Textmining |
|---|
Synonyms
| EC Number | Synonyms | Comment | Organism |
|---|---|---|---|
| 3.4.21.34 | porcine pancreatic kallikrein | - |
Sus scrofa |
| 3.4.21.34 | PPK | - |
Sus scrofa |
Expression
| EC Number | Organism | Comment | Expression |
|---|---|---|---|
| 3.4.21.34 | Sus scrofa | after oral administration of porcine pancreatic kallikrein formulation (10 units/kg or 20 unis/kg) to dogs, enzyme concentration in plasma reaches maximum 3 h after administration, and then decreases time-dependently | up |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
